Hepatitis C Sample Clauses

Hepatitis C. Chronic hepatitis C may affect three hundred million persons worldwide.1 Of these a significant number will progress to cirrhosis and thereafter to hepatocellular carcinoma.2 No vaccine currently exists for hepatitis C. Moreover, many individuals who become infected are not aware that they are infected. As a result, some do not seek treatment until irreversible liver damage has occurred. Accordingly, effective treatment remains essential.
Sample 1Sample 2
AutoNDA by SimpleDocs
Hepatitis C. 11. The ADOC’s medical care provider’s current clinical guideline for Hepatitis C is incorporated into this Settlement Agreement as though fully set forth herein. The clinical guideline for Hepatitis C may change from time to time as medically appropriate, so long as there is no decrease in the level of care or conflict with viral hepatitis guidelines issued by the Centers for Disease Control and Prevention or the National Institutes of Health.
Sample 1
Hepatitis C xxx.xxx. (xxxx://xxx.xxx.xxx/mediacentre/factsheets/fs164/en/). Updated July 9, 2019.
Sample 1
Hepatitis C. 27.4.1 The City/Department and the Union shall jointly develop a training program to address the dangers of Hepatitis C and implement a Hepatitis C testing program.
Sample 1
Hepatitis C. As soon as practicable following the successful conclusion of the Hepatitis C Trial and the U.S. Hepatitis C Trial, but in no event later than twelve (12) months following the completion of the observation period in the Hepatitis C Trial, Sigma-Tau will use its reasonable best efforts to prepare and file a marketing application with the EMEA, or alternatively with each country of the Territory, for use of Licensed Product to treat hepatitis C., under SPIL's trademark ZADAXIN, subject to the provisions of Sections 4.11 and 7.4.
Sample 1
Hepatitis C. The major source of transmission of hepatitis C is by exposure to infected blood and body fluids. Cases involving transmission of hepatitis C from surgeons to patients have been well documented and have arisen in the context of cardiothoracic surgery, open heart surgery, gynaecological surgery and anaesthesiology. HIV Transmission Studies have shown that the HIV virus can be transmitted to patients during both dental and surgical procedures.
Sample 1
Hepatitis C. The Code of Practice recommends that the following healthcare workers must be tested initially:
Sample 1
AutoNDA by SimpleDocs

Related to Hepatitis C

  • Conhecimento da Lingua O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da língua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condições estabelecidas no Plano e no Acordo de Atribuição (“Agreement” xx xxxxxx).

  • Anti-Terrorism The Contractor agrees to undertake all reasonable efforts to ensure that none of the UNDP funds received under the Contract is used to provide support to individuals or entities associated with terrorism and that recipients of any amounts provided by UNDP hereunder do not appear on the list maintained by the Security Council Committee established pursuant to Resolution 1267 (1999). The list can be accessed via xxxxx://xxx.xx.xxx/sc/suborg/en/sanctions/1267/aq_sanctions_list. This provision must be included in all sub-contracts or sub-agreements entered into under the Contract.

  • Acknowledgement of Anti-Predatory Lending Policies Buyer has in place internal policies and procedures that expressly prohibit its purchase of any High Cost Mortgage Loan.

  • Sanctions; Anti-Corruption None of the Borrower, any of its Subsidiaries, nor, to the knowledge of the Borrower, any director, officer, agent, Affiliate or employee of the Borrower or any of its Subsidiaries is currently (i) the subject of any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department or the U.S. State Department (“Sanctions”) or (ii) located, organized or resident in a country or territory that is, or whose government is, the subject of any Sanctions. None of the Borrower, any of its Subsidiaries nor, to the knowledge of the Borrower, any director, officer, agent, Affiliate or employee of the Borrower or any of its Subsidiaries, has taken any action, directly or indirectly, that would result in a violation in any material respect by any such Person of the United States Foreign Corrupt Practices Act of 1977, as amended (“FCPA”) or of any other anti-bribery or anti-corruption laws, rules, regulations legally applicable to such Persons (collectively, “Anti-Corruption Laws”). The Borrower will not use the proceeds of the Loans, or lend, contribute or otherwise make available such proceeds (a) to any Subsidiary, Affiliate, joint venture partner or other Person or entity, to fund the activities of any Person, or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of any Sanctions, or (b) directly, or, to the knowledge of the Borrower, indirectly, for any payments to any governmental official or employee, political party, official of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the FCPA or of any Anti-Corruption Laws.

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

Time is Money Join Law Insider Premium to draft better contracts faster.